Abstract
Integrated care is increasingly recognised as a key strategy for the management of multimorbidity. However, evidence on the factors associated with the implementation of integrated care models in low- and middle-income countries remains limited. We explored how stakeholders perceived integrated care, existing challenges, and recommendations for integrating cardiovascular disease and diabetes management at primary health care (PHC) level in Kenya. We conducted a qualitative study using key informant interviews with 16 key stakeholders involved in healthcare delivery, research, and policy on non-communicable diseases (NCDs) in Kenya between February and March 2024. All interviews were audio recorded and transcribed; and the data analysed both inductively and deductively within NVivo software. The deductive analysis was guided by the Rainbow Model of Integrated Care (RMIC) framework, which combines key dimensions necessary for successful integrated care with key elements of primary care. The RMIC framework dimensions include systems, clinical, organisational, professional, functional, and normative integration. Out of the six RMIC dimensions, stakeholders’ description of integrated care included elements of clinical, systems, and professional integration. Key systems level challenges included disparity between policy and practice, inadequate resource allocation, donor-driven priorities, and limited stakeholder collaboration. Fragmented care delivery was a key organisational challenge. Limited resources for integrated care delivery and inadequate staff numbers and capacity were considered key challenges in the functional and professional dimensions of the RMIC framework. Additional challenges included ‘siloed’ mindset (normative) and limited evidence on effective or cost-effective integrated care models. To address the identified barriers, policy-makers should develop clear and adaptable how-to county-specific guidelines for implementation and evaluation of integrated care at PHC level. There is a need for advocacy and research on models of integrated care at PHC level to guide prioritization and resource allocation in Kenya.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding support for this study was provided by Wellcome as part of a doctoral training grant [218462/Z/19/Z] at the University of Sheffield. The funder had no involvement in study design, collection, management, analysis and interpretation of data or the decision to submit for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by Moi Teaching and Referral Hospital/ Moi University Institutional Research and Ethics Committee (approval number 0004625), the University of Sheffield SCHARR research ethics committee, and a research permit granted by the National Commission for Science Technology and Innovation (NACOSTI) in Kenya (License number: NACOSTI/P/23/31904). All participants were taken through a detailed information sheet about the study after which they provided written informed consent prior to participation in the study. All the transcripts were anonymised during analysis and reporting to ensure confidentiality of study participants. The data were stored in a secure University of Sheffield file store only accessible to the researcher and the study team.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos